Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents - Modern Pathology
Identification of challenges and a framework for implementation of the AMP/ ASCO/CAP classification guidelines for reporting somatic variants - ScienceDirect
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer | Anticancer Research
Q&A column - CAP TODAY
ASCO 2020: HER2 Reclassification - Agendia Inc.
Implementation of the 2018 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2/neu Assessment by FISH in breast cancers: predicted impact in a single institutional cohort | Modern Pathology
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines.,JAMA Oncology - X-MOL
Update to ASCO/CAP Guideline in Breast Cancer: No Sweeping Changes, but Many Refinements - Cancer Therapy Advisor
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/9-Figure3-1.png "PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar")
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia - ScienceDirect
Mapping knowledgebase-specific evidence codes to AMP/ASCO/CAP... | Download Table
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update | Journal of Clinical Oncology
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows | BMC Medical Genomics | Full Text
What's New in the 2020 Update to the CAP/ASCO ER/PR Testing Guidelines in Breast Cancer?
Introduction:
HER2 spectrum of expression according to ASCO/CAP guidelines. HER2-low... | Download Scientific Diagram
Summary of ASCO/CAP HER2 testing recommendations 2007 and 2013 | Download Table
Breast cancer biomarkers, and a new clinical category for HER2 expression | Medical Laboratory Observer
Le linee guida ASCO/CAP 2018
HER2 IHC and Her2 FISH Criteria Under the 2007 and the 2013 ASCO/CAP... | Download Table
PPT - HER2 Testing in Breast Cancer: 2013 ASCO/CAP HER2 Guideline Update PowerPoint Presentation - ID:6109259
Oncology Times
2018 ASCO/CAP summary recommendations [original recommendations and... | Download Scientific Diagram
Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH - ScienceDirect
![PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b66331181b2eafa14b6e478dcc7fced0c7917993/3-Table1-1.png "PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar")
PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar
HER2 Status Determined by 2007 and 2013 ASCO/CAP Criteria, Respectively... | Download Table
